{
    "nctId": "NCT00769990",
    "briefTitle": "Genistein in Treating Patients Undergoing External-Beam Radiation Therapy for Bone Metastases",
    "officialTitle": "Phase I-II Trial of Genistein in Subjects Receiving Palliative External Beam Radiation Therapy for Osseous Metastases: A Study of Palliation of Symptoms and Quality of Life",
    "overallStatus": "WITHDRAWN",
    "conditions": "Breast Cancer, Kidney Cancer, Lung Cancer, Melanoma, Metastatic Cancer, Pain, Prostate Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE1, PHASE2",
    "allocation": "NA",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 0,
    "primaryOutcomeMeasure": "Safety",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Histologically confirmed malignant solid tumor, including any of the following:\n\n  * Breast cancer\n  * Lung cancer\n  * Kidney cancer\n  * Melanoma\n  * Prostate cancer\n* Radiographic evidence\\* of bone metastasis within the past 8 weeks NOTE: \\*Acceptable studies include plain radiograph, radionuclide bone scan, CT scan, and MRI\n* Has pain that appears to be related to the radiographically documented metastasis, in the opinion of the treating physician, AND a decision has been made by the responsible clinician that a course of palliative external beam radiotherapy is appropriate treatment\n\n  * \"Worst pain score\" of \\> 5 on a scale of 10 as scored on the pain assessment questionnaire (BPI) (question #3: 0 = no pain; 10 = worst possible pain) OR taking narcotic medications with an oral morphine equivalent dose of \\> 60 mg/day\n  * No painful metastases to the skull, hands, or feet\n* Eligible treatment sites include any of following:\n\n  * Weight-bearing sites:\n\n    * Pelvis (excluding pubis)\n    * Femur\n    * Sacrum and/or sacroiliac joints\n    * Tibia\n  * Non-weight-bearing sites:\n\n    * Up to 5 consecutive cervical, thoracic, or lumbar vertebral bodies\n    * Lumbosacral spine\n    * Up to 3 consecutive ribs\n    * Humerus\n    * Fibula\n    * Radius \u00b1 ulna\n    * Clavicle\n    * Sternum\n    * Scapula\n    * Pubis\n* If multiple osseous sites are treated, the treatment site is included as weight-bearing if any of the sites include the pelvis, sacrum, femur, or tibia\n\n  * Treatment of multiple osseous sites allowed only if those sites can be included in \u2264 3 treatment sites\n* Patients with painful metastases that are contiguous but do not fit into the definition of a site listed above are eligible but are considered to have 2 treatment sites\n* No vertebral metastases with clinical or radiographic evidence of spinal cord or cauda equina compression/effacement\n* No primary hematologic malignancies (e.g., lymphoma)\n* Hormone receptor status (for patients with breast cancer):\n\n  * Estrogen receptor-negative tumor\n* Menopausal status not specified\n* Karnofsky performance status 40-100%\n* Life expectancy \u2265 3 months\n* ALT normal\n* Bilirubin normal\n* Serum creatinine normal (\u2264 1.8 mg/dL for males and \u2264 1.5 mg/dL for females)\n* Free T4 and thyroid-stimulating hormone normal\n* Not pregnant\n* Negative pregnancy test\n* Fertile patients must use effective contraception\n* No pathologic fracture or impending fracture of the treatment site\n* No history of primary hyperparathyroidism\n* No malabsorptive disease or chronic diarrhea\n* No history of sarcoidosis or tuberculosis\n\nExclusion Criteria:\n\n* Less than 30 days since prior systemic radioisotopes for pain, including Strontium-90 (\\^90Sr) or Samarium (\\^153Sm)\n* Less than 30 days since prior antibiotics\n* Less than 30 days since prior initiation of systemic therapy (e.g., hormonal therapy, chemotherapy, or immunotherapy)\n* Less than 90 days since prior intravenous bisphosphonate therapy\n\n  * Concurrent oral bisphosphonates allowed\n* Prior radiotherapy or palliative surgery to the painful sites\n* Concurrent surgical fixation of the bone\n* Concurrent treatment to the skull, hands, or feet",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}